Literature DB >> 9374350

Parathyroid hyperplasia, thymic carcinoid and pituitary adenoma detected with technetium-99m-MIBI in MEN type I.

J E Perez-Monte1, M L Brown, M R Clarke, C G Watson, S E Carty.   

Abstract

We report a case of a 57-yr-old woman with history of multiple endocrine neoplasia type I (MEN I). A 99mTc-sestamibi scan demonstrated a hyperplastic parathyroid gland, a large anterior mediastinal mass and a pituitary adenoma during a study done to evaluate recurrent hyperparathyroidism. The importance of this case is that much of the nonparathyroid pathology in patients with MEN I syndrome may be detected with this one study.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9374350

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  8 in total

1.  Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients.

Authors:  Radu Mihai; Fergus Gleeson; Ian D Buley; Derek E Roskell; Gregory P Sadler
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

2.  Thymic carcinoid and parathyroid hyperplasia detection with 99mTc-MIBI men type 1.

Authors:  C Marí; J León; J Farrerons; X Matis-Guiu; A Tembl; J C Martin; A Flotats; L l Bernà
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

3.  Visualisation of a paraganglioma by technetium-99m-sestamibi scintigraphy.

Authors:  M Piga; G P Farina; G L Loi; A Serra; M A Calia; L Lai; G Zucca; S Mariotti
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

4.  The early diagnosis of multiple endocrine neoplasia type 1 (MEN 1): a case report.

Authors:  G Tamagno; E De Carlo; C Martini; D Rubello; F Fallo; N Sicolo
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

5.  Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).

Authors:  Pierre Goudet; Arnaud Murat; Catherine Cardot-Bauters; Philippe Emy; Eric Baudin; Hélène du Boullay Choplin; Yves Chapuis; Jean-Louis Kraimps; Jean-Louis Sadoul; Antoine Tabarin; Bruno Vergès; Bruno Carnaille; Patricia Niccoli-Sire; Annie Costa; Alain Calender
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

6.  The value of Tc-99m tetrofosmin in the imaging of pituitary adenomas.

Authors:  N Kurtulmus; C Turkmen; S Yarman; H Tokmak; A Mudun
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

7.  The EANM practice guidelines for parathyroid imaging.

Authors:  Petra Petranović Ovčariček; Luca Giovanella; Ignasi Carrió Gasset; Elif Hindié; Martin W Huellner; Markus Luster; Arnoldo Piccardo; Theresia Weber; Jean-Noël Talbot; Frederik Anton Verburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-10       Impact factor: 9.236

8.  Pituitary incidentalomas detected with technetium-99m MIBI in patients with suspected parathyroid adenoma: preliminary results.

Authors:  Ekaterina Tiktinsky; Tifha Horne; Michael Friger; Svetlana Agranovich; Sophie Lantsberg
Journal:  World J Nucl Med       Date:  2012-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.